Matches in Nanopublications for { ?s ?p "[Loss of heterozygosity at the hMLH1 and hMSH2 gene loci were observed in 4% (1/25 informative cases) and 6.1% (2/33) of EHBD cancer cases, respectively; and in 11.1% (1/9) and 8.3% (1/12) of ampullary cancer cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP570035.RADGEwwibw_qjJ9Tt41OvzolXWAExLPofmJbqNASLNvjY130_assertion description "[Loss of heterozygosity at the hMLH1 and hMSH2 gene loci were observed in 4% (1/25 informative cases) and 6.1% (2/33) of EHBD cancer cases, respectively; and in 11.1% (1/9) and 8.3% (1/12) of ampullary cancer cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570035.RADGEwwibw_qjJ9Tt41OvzolXWAExLPofmJbqNASLNvjY130_provenance.
- assertion description "[Loss of heterozygosity at the hMLH1 and hMSH2 gene loci were observed in 4% (1/25 informative cases) and 6.1% (2/33) of EHBD cancer cases, respectively; and in 11.1% (1/9) and 8.3% (1/12) of ampullary cancer cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_assertion description "[Loss of heterozygosity at the hMLH1 and hMSH2 gene loci were observed in 4% (1/25 informative cases) and 6.1% (2/33) of EHBD cancer cases, respectively; and in 11.1% (1/9) and 8.3% (1/12) of ampullary cancer cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_provenance.